Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358070 · ClinicalTrials.gov registry record
Epidemiologic Study of Hepatocellular Carcinoma in the US
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 45
- Enrollment target
NCT02358070: Completed study, sponsored by Stanford University.
NCT02358070 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02358070 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is: * to investigate the risk factors of HCC among Americans with focus on lifestyle factors and energy balance. * to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated with HCC risk through a genome-wide search. * to assess if genetic susceptibility differs by hepatitis virus infection or lifestyle factors, and to explore if there are interplays or effect modifications between genetic factors and viral infection or lifestyle factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02358070
The ClinicalTrials.gov registry entry for NCT02358070 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02358070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02358070 about?
NCT02358070 is a clinical study titled "Epidemiologic Study of Hepatocellular Carcinoma in the US". The purpose of this study is: * to investigate the risk factors of HCC among Americans with focus on lifestyle factors and energy balance. * to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated with HCC risk through a genome-wide search. * to assess if genetic susce...
What is the current status of trial NCT02358070?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2015-04. Estimated completion is 2016-09-01.
Who is sponsoring clinical trial NCT02358070?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.